Top Biotech ETF Длинная

Range Cancer Therapeutics ETFNASDAQ

Описание

⋅ 6 мар 2018 г., 02:58

This is CNCR Loncar Cancer Immunotherapy ETF, it is trading +25% year to date, some of its 30 holdings are ATRA, IOVA, NKTR, JNCE, BGNE, ACEN, 64% in Micro Cap, last price $30.60, expense ratio 0.79%. We are bullish on it and you could too.

Ещё